Guided Therapeutics, Inc.
GTHP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $87 | $185 | $115 | $388 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $8 | $2 | $3 |
| Inventory | $583 | $595 | $633 | $633 |
| Other Curr. Assets | $123 | $23 | $61 | $173 |
| Total Curr. Assets | $799 | $811 | $811 | $1,197 |
| Property Plant & Equip (Net) | $87 | $112 | $139 | $164 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $17 | $17 | $17 | $17 |
| Total NC Assets | $104 | $129 | $156 | $181 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $903 | $940 | $967 | $1,378 |
| Liabilities | – | – | – | – |
| Payables | $2,382 | $2,292 | $2,186 | $2,130 |
| Short-Term Debt | $2,339 | $2,229 | $1,915 | $2,047 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $689 | $679 | $670 | $849 |
| Other Curr. Liab. | $1,060 | $1,177 | $1,128 | $1,129 |
| Total Curr. Liab. | $6,470 | $6,377 | $5,899 | $6,155 |
| LT Debt | $29 | $35 | $116 | $112 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $29 | $35 | $96 | $112 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $104 | $130 | $155 |
| Total Liabilities | $79 | $6,412 | $5,995 | $6,267 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $2,182 | $2,196 | $2,999 |
| Common Stock | $0 | $3,465 | $3,464 | $3,452 |
| Retained Earnings | $0 | -$155,028 | -$154,172 | -$153,709 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $824 | $143,909 | $144,355 | $142,369 |
| Total Equity | $824 | -$5,472 | $871 | -$4,889 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $903 | $940 | $967 | $1,378 |
| Net Debt | $2,281 | $2,079 | $1,916 | $1,771 |